Researchers have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers. The results show ...

Biotech leaders at a Stanford symposium normally focused on the future couldn’t help but grapple with a present clouded by ...

As a descendant of an Indigenous Amazonian tribe, Maria Astolfi was concerned about research she conducted as a graduate ...

Fueled by a unique blend of innovation, talent, and collaboration, Austin has built a reputation as a tech powerhouse, but ...

At this year's South by Southwest (SXSW) conference in Austin, Texas, Future Today Strategy Group founder and CEO Amy Webb ...

Recent developments in health highlight key agreements between countries, drug approvals, corporate revenue growth, and ...

Protein Engineering Market IntroductionThe protein engineering market is rapidly evolving, driven by the need to develop proteins with improved functionality for a range of applications, including ...

Nautilus Biotechnology, Inc. ( NASDAQ: NAUT) Q1 2025 Earnings Conference Call April 29, 2025 8:30 AM ET Ji-Yon Yi - Head, Investor Relations Sujal Patel - Co-Founder & Chief Executive Officer Parag ...

Commissioners visit UD-based NIIMBL, where public-private partnerships promote innovation, workforce development ...

WALTHAM, MASSACHUSETTS / ACCESS Newswire / April 28, 2025 / Data4Cure, Inc., a leading biomedical data-to-knowledge company, today announced the presentation of two new research abstracts at the 2025 ...